Oncolytics Biotech Inc T.ONC

Alternate Symbol(s): ONCY

Healthcare Biotechnology

Oncolytics Biotech Inc. is a clinical-stage biotechnology company. The Company is focused on developing pelareorep, an intravenously delivered immunotherapeutic agent that activates the innate and adaptive immune systems and weakens tumor defense mechanisms. This compound induces anti-cancer immune responses and promotes an inflamed tumor phenotype turning cold tumors hot through innate and adaptive immune responses to treat a variety of cancers. This improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatments. The Company’s primary focus is to advance its programs in hormone receptor-positive / human epidermal growth factor 2- negative (HR+/HER2-) metastatic breast cancer and advanced/metastatic pancreatic ductal adenocarcinoma to registration-enabling clinical studies. In addition, it is exploring opportunities for registrational programs in other gastrointestinal cancers through its GOBLET platform study.

TSX:ONC - Post by User

Oncolytics Biotech Inc > New presentation on the website if interested

<< Previous

Bullboard Posts

Next >>

Comment by Azzak34on Jan 30, 2024 2:33pm

106 Views

Post# 35853203

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:New presentation on the website if interested

You know my new favorite Buckster? People are actually pumping Agenus as an alternative to ONCY because their "results are better" and they have a massive amount of institutional ownership. Take a minute and go see how they've been doing. 56% institutional ownership. Come back to me with your findings Bucko.

<< Previous

Bullboard Posts

Next >>

Rick Rule’s election insights: Gold, USD, and Canadian gas